Subcutaneous Administration of Cefepime Paul Walker, MD, Melinda N. Neuhauser, PharmD, Vincent H. Tam, PharmD, Jie S. Willey, BSN, MSN, J. Lynn Palmer, PhD, Eduardo Bruera, MD, Randall A. Prince, PharmD Journal of Pain and Symptom Management Volume 30, Issue 2, Pages 170-174 (August 2005) DOI: 10.1016/j.jpainsymman.2005.03.007 Copyright © 2005 U.S. Cancer Pain Relief Committee Terms and Conditions
Figure 1 Observed versus MAP Bayesian-predicted cefepime concentrations from population pharmacokinetic model using median parameter estimates. Journal of Pain and Symptom Management 2005 30, 170-174DOI: (10.1016/j.jpainsymman.2005.03.007) Copyright © 2005 U.S. Cancer Pain Relief Committee Terms and Conditions
Figure 2 Simulated first dose pharmacokinetic profile based on median parameter estimates. Journal of Pain and Symptom Management 2005 30, 170-174DOI: (10.1016/j.jpainsymman.2005.03.007) Copyright © 2005 U.S. Cancer Pain Relief Committee Terms and Conditions